Microbot Medical (NASDAQ: MBOT) has entered into an agreement with closely held Lovell Government Services to serve federal healthcare systems, establishing Lovell as Microbot’s Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor to serve these customers through federal contracting systems.
Under the agreement, the company will sell its LIBERTY Endovascular Robotic System at more than 2,000 government facilities, including those administered by the U.S. Department of Veterans Affairs, the Department of Defense, and the Indian Health Service. Lovell has been a SDVOSB vendor since 2013 with a track record of introducing suppliers to the government market.
In a statement, Chris Lovell, Major, USMC (Ret.), CEO of Lovell, commented, “We are proud to partner with Microbot Medical to help expand access to innovative healthcare technologies for our nation’s veterans, active-duty service members, and Native American communities. The LIBERTY Endovascular Robotic System represents a significant advancement in minimally invasive vascular care, and we look forward to supporting its availability across federal healthcare systems. Our mission is to connect government providers with best-in-class solutions that improve patient outcomes while simplifying the procurement process, and this partnership reflects that commitment.”
